LIFEVANTAGE CORP Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
LIFEVANTAGE CORP (LFVN) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 200.00 thousand shares for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-04.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2025-09-04
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2024-03-31 was 100.00K shares, a 614.29% increase year-over-year.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-06-30 was 11.00K shares.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-03-31 was 14.00K shares.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2025 was 200.00K shares, a 0.00% change from fiscal 2024.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2024 was 200.00K shares, a 325.53% increase from fiscal 2023.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2023 was 47.00K shares, a 20.51% increase from fiscal 2022.
- LIFEVANTAGE CORP share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2022 was 39.00K shares, a 61.00% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2025-06-30 | 200.00K shares 10-K · filed 2025-09-04 | |||
| 2024-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | 100.00K shares derived: sum of 2 quarters · filed 2025-09-04 | 200.00K shares 10-K · filed 2025-09-04 | |
| 2024-03-31 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | 200.00K shares 10-Q · filed 2024-05-02 | ||
| 2023-12-31 | 100.00K shares 10-Q · filed 2024-01-30 | |||
| 2023-06-30 | 11.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | 25.00K shares derived: sum of 2 quarters · filed 2024-08-28 | 47.00K shares 10-K · filed 2024-08-28 | |
| 2023-03-31 | 14.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | 36.00K shares 10-Q · filed 2024-05-02 | ||
| 2022-12-31 | 22.00K shares 10-Q · filed 2024-01-30 | |||
| 2022-06-30 | 39.00K shares 10-K · filed 2023-08-28 | |||
| 2021-06-30 | 100.00K shares 10-K · filed 2022-08-23 | |||
| 2020-06-30 | 400.00K shares 10-K · filed 2022-08-23 | |||
| 2019-06-30 | 200.00K shares 10-K · filed 2021-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |